Here you can have access to some of our more relevant news.
Aptadel Therapeutics awarded Eurostars grant
Aptadel Therapeutics awarded Eurostarsgrant for a first-in-class RNA-basedtargeted therapy for childhood...Read More
Dr. Gisela Lorente, CSO at Aptadel Therapeutics, has been interviewed by Biocat
Startup Generator is the space reserved at Biocat for interviews and...Read More
Aptadel Therapeutics has participated in the 2021 Richi Entrepreneurs Boston Immersion Program.
2021 Richi Entrepreneurs Boston Immersion Program organized by the RichiFoundation has...Read More
Aptadel has been one of the 11 start up selected in the BCN Health Booster programme.
Aptadel has been one of the 11 start up selected in...Read More
Aptadel Therapeutics settles in the Barcelona Science Park and raises $2.1M in Seed Financing Round.
Aptadel Therapeutics, a pre-clinical biomedical company focused on developing a RNA-based...Read More